Stephanie E. Weiss, MD
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
Virtua Fox Chase Cancer Program
239 Hurffville Crosskeys Rd, Ste 190
Sewell, NJ 08080
Video: Stephanie E. Weiss, MD
Adult malignant and benign tumors of the Central Nervous System
American Board of Radiology, Radiation Oncology
It has been my long-term ambition to treat patients suffering from cancer. Even before medical school, I had been a member of a cancer research team at Mount Sinai Hospital in New York City where I had the opportunity to contribute to several scientific publications on the subject of breast cancer. As a medical student at St. George’s University School of Medicine I pursued this interest by taking a number of electives in the field. I chose to specialize in radiation oncology because it affords me the opportunity to interact directly with patients on a daily basis and to participate in clinical research programs designed to explore new treatment modalities.
After my internship at Upstate Medical University in NY, I trained in radiation oncology at Johns Hopkins Hospital and obtained broad experience in all subspecialty areas of radiation oncology. In my final year I was appointed as Chief Resident.
Following completion of my residency I received an appointment as attending physician at Brigham and Women’s Hospital/Dana Farber Cancer Institute and was on faculty at Harvard Medical School. I specialized in the treatment of brain tumors and in 2007 was appointed Chief of Adult Tumors of the Central Nervous System Tumors and Radiosurgery.
I have extensive experience with several technologies used in treating cancer patients including stereotactic radiosurgery, hypo-fractionation, volumetric arc therapy and intensity modulated radiotherapy. My research activities are primarily involved in seeking to improve outcomes for patients, and has been presented at national and international meetings, won grants, and been selected for plenary sessions. (see publications).
In 2012 I joined the Department of Radiation Oncology at Fox Chase Cancer Center as attending physician and Associate Professor. I will continue to be involved in the treatment of patients with cancer and also contribute to the development of the brain tumor service. My clinical research activities will, as in the past, focus on developing and assessing new treatment protocols that will provide better outcomes for patients.
As a member of several national and international professional organizations I regularly avail of the opportunity to share and exchange expertise with other specialists in the field. This allows me to continue giving my patients the best in current care.
My treatment philosophy is patient-centered. I believe that patients should be integrally involved in decision making at all stages of their treatment programs. It is my belief that a strong relationship with each patient is central to selecting the best treatment program for his or her clinical needs. Patient confidence is something that I prize highly and constantly strive to attain. Community outreach is also important to me and I regularly contribute to education programs and symposiums organized for the benefit of patients and their families to update them on specific topics pertaining to patient treatment and management.
Finally, it is a great pleasure to me to contribute to the future development of the field of Radiation Oncology through participation in the training programs at Fox Chase Cancer Center for younger colleagues, students, residents and fellows.
MD, St. George’s University School of Medicine, University Centre, Grenada, West Indies, 1999
Chief Resident, Radiation Oncology, Johns Hopkins Sidney Kimmel Cancer Center, 2002-2004;
Resident, Radiation Oncology, Johns Hopkins Sidney Kimmel Cancer Center, 2000-2002
Honors and Awards
STAR Award for Outstanding Physician, Upstate Medical University, 2000
American Society for Therapeutic Radiology and Oncology (ASTRO);
European Association of Neuro-Oncology;
European Society of Therapeutic Radiation Oncology;
International Stereotactic Radiosurgery Society;
Radiological Society of North America;
Society of Neuro-Oncology;
Society of Translational Oncology
Adult Brain tumors; Radiosurgery; Hypofractionated radiation
Dr. Weiss on PubMed
- Heron DE, Beal K, Wagner H, Allen A, Weiss SE, Shoshan Y, Tomblyn MB, Davidson ILAN, Ben-Ami M. Apoptosis imaging with 18F-ML-10 for early detection of response of brain metastases to stereotatic radiosurgery. Radiotherapy and Oncology. 2012 103(3)
- Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4)
- Kelly PJ, Lin NU, Claus EB, Quant EC, Weiss SE, Alexander BM. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors. Cancer. 2012 Apr 15;118(8):2014-20.
- Kelly PJ, Lin YB, Yu AY, Alexander BM, Hacker F, Marcus KJ, Weiss SE. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):95-101.
- Arvold ND, Hsu L, Chen WY, Benzaquen LR, Weiss SE. Marantic endocarditis with cardioembolic strokes mimicking leptomeningeal metastases in breast cancer. J Clin Oncol. 2011 Oct 10;29(29):e743-6.
- Kelly PJ Dinkins MJ, Drappatz J, O’Regan KN, Weiss SE. Unexpected late radiation neurotoxicity following Bevacizumab after radiation to the central nervous system. Journal of Neuro-Oncology102(3):485, 2011
- Kelly PJ, Lin YB, Yu AY, Ropper AE, Nguyen PL, Marcus KJ, Hacker FL, Weiss SE. Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience. Kelly PJ, Lin YB, Yu AY, Ropper AE, Nguyen PL, Marcus KJ, Hacker FL, Weiss SE. J Neurooncol. 2011 Sep;104(2):553-7.
- Horky L; Hsiao EH; Drappatz J; Weiss SE; Gerbaudo VH. Dual Phase FDG-PET imaging of brain metastases provides superior assessment for recurrence versus necrosis. Journal of Neuro-Oncology103(1):137-46. 2010
- Kelly PJ, Weiss SE, Sher DJ, Perez-Atayde AR, Dal Cin P, Choueiri TK. Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma. J Clin Oncol. 2010 Sep 1;28(25):e433-5.
- Weiss SE, Kelly PJ. Neurocognitive function after WBRT plus SRS or SRS alone. Lancet Oncol. 2010 Mar;11(3):220-1.
- Metellus P, Batra S, Karkar S, Kapoor S, Weiss SE, Kleinberg L, Rigamonti D. Fractionated conformal radiotherapy n the management of cavernous sinus meningiomas: Long-term functional outcome and tumor control at a single institution. International Journal of Radiation Oncology Biology and Physics.78(3):836-43. 2010
- Drappatz J, Norden AD, Wong ET, Doherty LM, LaFrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Ligon KL, Young G, Muzikansky A, Weiss SE, Wen PY. Phase I Study of Vandetanib with radiotherapy and Temozolomide for newly diagnosed glioblastoma. International Journal of Radiation Oncology Biology and Physics 78(1):85-0. 2010
- Weiss, SE “Supportive care:Controlling symptoms and diminishing toxicities.”in Brain Metastasis: A multidisciplinary approach; 1st Edition; ed: Lawrence Kleinberg. Demos Publishing 2008
- Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro-oncology Jul;9(3):354-63. 2007.
- Chheda MG; Drappatz J, Greenberg NJ, Kesari S, Weiss SE, Gigas DC, Doherty LM, Wen PY: Hepatitis B reactivation during glioblastoma treatment with temozolomide: A cautionary note Neurology March:68: 955-56. 2007.
- Weiss SE; O’Connor L; Welsh JS. Refinement of radiation therapy based on PET data in an adult with Langerhans cell histiocytosis of soft tissues. ClinAdvHematolOncol. Apr;4(4):290-2; discussion 292-4. 2006.
- Weiss SE, Kleinberg LR, Wharam MD, Rigamonti D. “Fractionated stereotactic radiotherapy in the treatment of acoustic neuroma” in Cancer of the Nervous System. 2nd edition; Peter McL. Black and Jay S. Loeffler.
- Tartter PI, Weiss SE,Ahmed S, Kamath S, Herman G, Drossman S. Mammographically occult breast cancers. Breast J. Jan;5(1):22-25.1999.
- Cunningham JD, Weiss SE, Ahmed S, Bratton J, Bleiweiss IJ, TartterPI, Brower S. The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Invest. 16(2): 80-6. 1998.
- Brower ST, Tartter PI, Weiss SE, Luderer A, Lehrer S. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors. Mt. Sinai J Med Nov; 62(6): 419-21. 1995.
- Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, Bratton J, Amberson JB. Author reply. Cancer. Feb 1; 77(3):594-594. 1996.
- Brower ST, Tartter PI, Weiss SE, Luderer A, Lehrer S. Reproductive history and prognosis in patients with operable breast cancer. Cancer. Aug 1; 76(3): 531-3. 1995
- Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco CM, Bossolt K, Hayden C, Bleiweiss IJ. Ethnic differences in risk and prognostic factors for breast cancer. Cancer. Jul 15; 76(2): 268-74.